Acta Scientific Otolaryngology (ASOL) (ISSN: 2582-5550)

Case Report Volume 4 Issue 9

Mucormycosis and COVID-19: A Case Report

Milene Lopes Frota*, Ana Luiza Nunes França, Carolina Pontes Oliveira Nunes, Lays Mylena Silva Ribana Lacerda Merlin and Mirian Cabral Moreira de Castro

Otolaryngology Department, Santa Casa de Belo Horizonte, Brazil

*Corresponding Author: Milene Lopes Frota, Otolaryngology Department, Santa Casa de Belo Horizonte, Brazil.

Received: July 18, 2022; Published: August 05, 2022


The presence of co-infections in individuals with coronavirus disease 2019 (COVID-19) makes the management of these patients more challenging. The following is a case report of a patient with a history of untreated diabetes mellitus who was diagnosed in March 2021 with severe acute respiratory syndrome due to COVID-19, consequently developing rhino–orbital mucormycosis. Despite the severity of the condition, the patient demonstrated an excellent recovery course following surgical intervention and clinical treatment with isavuconazole.

Keywords: Case Report; Co-infection; Covid-19; Mucormycosis


  1. Sen M., et al. “Epidemiology, clinical profile, management, and outcome of COVID-19-associated rhino-orbital- cerebral mucormycosis in 2826 patients in India - collaborative OPAI-IJO study on mucormycosis in COVID-19 (COSMIC), report”. Indian Journal of Ophthalmology7 (2021): 1670-1692.
  2. Singh AK., et al. “Mucormycosis in COVID-19: A systematic review of cases reported worldwide and in India”. Diabetes and Metabolic Syndrome 4 (2021): 102146.
  3. Sharma S., et al. “Post coronavirus disease mucormycosis: a deadly addition to the pandemic spectrum”. Journal of Laryngology and Otology (2021): 442-447.
  4. Ahmadikia K., et al. “The double-edged sword of systemic corticosteroid therapy in viral pneumonia: A case report and comparative review of influenza-associated mucormycosis versus COVID-19 associated mucormycosis”. Mycoses (2021): 1-11.
  5. Shirley M and Scott LJ. “Isavuconazole: A review in invasive aspergillosis and mucormycosis”. Drugs 17 (2016): 1647-1657.


Citation: Milene Lopes Frota., et al. “Mucormycosis and COVID-19: A Case Report".Acta Scientific Otolaryngology 4.9 (2022): 04-06.


Copyright: © 2022 Milene Lopes Frota., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.


Acceptance rate34%
Acceptance to publication20-30 days
Impact Factor0.871

Indexed In

News and Events

Contact US